PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > Formulary Search

Search

Reset

BNF Chapter

BNF Paragraph

Please select a BNF Chapter.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : V

Records returned : 34 (on 21 Nov 2024 at 16:49:22).

Drug
Indication
Status
Trust Alignment
Links
Restrictions/Comments
Valaciclovir
No Information Returned
Valdecoxib
No Information Returned
Valganciclovir hydrochloride
No Information Returned
Valproic acid
No Information Returned
02.05.05
Valsartan
Hypertension
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
NICE
02.05.05
Valsartan
Heart failure
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
Valsartan with diuretic
No Information Returned
Valsartan/amlodipine
No Information Returned
05.01.07
11.03.01
Vancomycin hydrochloride
Clostridioides difficile
Green
Formulations :
  • Capsules
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. The APC notes that although current NICE guidelines recommend vancomycin first line for treatment of C diff, it is recognised that this was based on cost and in exceptional cases when a liquid is required, fidaxomicin granules are appropriate to prescribe as a licensed preparation that supports timely treatment.
05.01.07
11.03.01
Vancomycin hydrochloride
Bacterial infection
Red
Formulations :
  • Infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
R
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. This drug requires therapeutic monitoring.
05.01.07
11.03.01
Vancomycin hydrochloride
Endophthalmitis
Red
Formulations :
  • Intravitreal injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Un
Important
Ophthalmology specialists only.
05.01.07
11.03.01
Vancomycin hydrochloride
Bacterial keratitis / corneal ulcer
Red
Formulations :
  • Eye drops (preservative free)
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
U
Important
5% preservative free eye drops (unlicensed). Under microbiology guidance. Ophthalmology only.
Vandetanib
No Information Returned
07.04.01
07.04.05
Vardenafil
Penile rehabilitation
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
07.04.01
07.04.05
Vardenafil
Erectile dysfunction combination therapy
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
07.04.01
07.04.05
Vardenafil
Benign prostatic hyperplasia
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
07.04.01
07.04.05
Vardenafil
Erectile dysfunction
Non Formulary
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF SPC
NFD1
Varenicline tartrate
No Information Returned
Varicella vaccine live
No Information Returned
Varicella-zoster immunoglobulin
No Information Returned
Vecuronium bromide
No Information Returned
01.05.03
Vedolizumab
Inflammatory bowel disease
Red
Formulations :
  • Infusion
  • Subcutaneous injection (sc)
ASPH
RSFT
SASH
SABP
Primary Care
Guidelines BNF NICE SPC
ICB
BlueTeq
NICE
Important
Not 1st line. Only in patients where steroids and/or TNF inhibitor not effective / appropriate
01.05.03
Vedolizumab
Immunotherapy related colitis
Red
Formulations :
  • Subcutaneous injection (sc)
  • Intravenous infusion
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Only after steroids and infliximab (1st-line) have been ineffective
01.05.03
Vedolizumab
Pouchitis
See narrative
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD2
Vemurafenib
No Information Returned
Venlafaxine
No Information Returned
02.06.02
Verapamil hydrochloride
Arrhythmias
Green
Formulations :
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.06.02
Verapamil hydrochloride
Angina
Green
Formulations :
  • Modified release capsules
  • Modified release tablets
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.06.02
Verapamil hydrochloride
Angina
Green
Formulations :
  • Oral solution
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
02.06.02
Verapamil hydrochloride
Arrhythmias
Red
Formulations :
  • Injection
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Vericiguat
No Information Returned
Verteporfin
No Information Returned
04.08.01
Vigabatrin
Epilepsy
Blue
Formulations :
  • Sachets (powder)
  • Tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Important
Specialist initiation before transfer of prescribing to primary care
04.08.01
Vigabatrin
Epilepsy
Non Formulary
Formulations :
  • Soluble tablets
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
NFD1
Vildagliptin
No Information Returned
Vinblastine sulfate
No Information Returned
Vincristine sulfate
No Information Returned
Vindesine sulfate
No Information Returned
Vinorelbine
No Information Returned
Vismodegib
No Information Returned
Vitamin A
No Information Returned
Vitamin B and C injection
No Information Returned
Vitamin B compound
No Information Returned
Vitamin E
No Information Returned
Vitamins caps
No Information Returned
05.02.01
Voriconazole
Fungal infection
Red
Formulations :
  • Not Specified
ASPH
RSFT
SASH
SABP
Primary Care
BNF SPC
Vortioxetine
No Information Returned
 

For information about the icons and status values within this site, please refer to the keys below.

Icon/Links Key

NFD1
Non formulary
NFD2
Not assessed for formulary status. Apply to APC / DTC before use.
CD
Controlled drug. Prescribing and/or storage requirements may apply
R
Restrictions apply
SA
Safety Alert
U
Unlicensed - no UK marketing license in place
Un
Off-label use. Not licensed for this indication.
NHSE
Treatment commissioned by NHS England
CDF
CDF
ICB
Treatment commissioned by the ICB
BlueTeq
BlueTeq form to be completed
NICE
NICE

Traffic Light Status Key

Red
Specialist ONLY drugs - treatment initiated and continued by specialist clinicians
Amber
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement
Green
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.
Black
Now referred to as "Non Formulary" but some BLACK drugs remain pending review. Not recommended for use in any health setting across Surrey and NW Sussex health economy.
Amber Star
Now referred to as "Blue" but some Amber Star drugs remain pending review. Prescribing initiated and stabliised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green (see narrative)
GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.
Non Formulary
Not recommended for use in any health setting across Surrey and NW Sussex health economy. (Formerly BLACK traffic light status)
See Below
Please add a description.
N/A
Please add a description.
Blue
Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.
Green - Black
Now referred to as "Do not initiate in new patients" but some GREEN/BLACK drugs remain pending review. These drugs are NOT for new initiations (BLACK, (now referred to as Non Formulary)) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required.
See narrative
See narrative - is applied in instances where there may be more than one traffic light status for a drug. This occurs when the traffic light status may differ between specific cohorts of patients e.g. those of childbearing potential and those who are not (in the case of sodium valproate)
Do not initiate in new patients
These drugs are NOT for new initiations (Non Formulary) but prescribing for existing patients may continue (GREEN). Please refer to the narrative on the Drug Profile page for further information if required. (Formerly GREEN/BLACK traffic light status)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More